6505--Eszopiclone Tablets - Golden State Medical Supply, Inc.

Solicitation / RFP / RFQ

This document is a solicitation for Eszopiclone Tablets, with the contracting office located in ZIP code 60141. The solicitation number is 36E79725R0070.

The primary requirement is the supply of Eszopiclone Tablets.

This solicitation is associated with an award made on 01-29-2026 with an award number of 36E79726D0018. The total award amount was $5,537,389.48.

Not explicitly detailed in the provided text, but the award information suggests a procurement process has concluded.

Not specified in the provided text.

• Product Service Code: 6505
• NAICS Code: 325412
• The awardee is GOLDEN STATE MEDICAL SUPPLY, INC. (UEI: GQLDJJ8AQNN5), located at 5187 CAMINO RUIZ, CAMARILLO, CA 93012.
• The Point of Contact is Richard Mahario, Contract Specialist, at Richard.Mahario@va.gov or 708-786-5247.

Amendment / Modification

This amendment extends the deadline for submitting offers.

• The "HOUR & DATE for Receipt of Offers" is extended.

• The due date and time for receipt of offers is extended to December 2, 2025, at 2:30 PM Central Standard Time (CST).

• Offerors must complete, sign, and submit this amendment with all other offer documents by the new deadline.

Solicitation / RFP / RFQ

This solicitation seeks proposals for the supply of Eszopiclone tablets in various strengths (1mg, 2mg, 3mg) for the Department of Veterans Affairs (VA) and Department of Defense (DoD) Pharmaceutical Prime Vendor (PPV) Programs. The objective is to establish a supply source for these drugs, ensuring nationwide availability and obtaining volume-based pricing.

• Eszopiclone tablets in 1mg, 2mg, and 3mg strengths.

• Packaging: 30 tablets per bottle (Unit of Use).

• Bottles must have a minimum 120cc volume, cylindrical body, minimum 5.75" circumference, and fit a 5.25" x 2" label.

• Bottles must include a safety cap (deshellable or convertible) and meet specific bottle and label dimensions.

• All offered products must be FDA approved and manufactured in FDA cGMP acceptable facilities.

• Offerors must provide a unique 11-digit National Drug Code (NDC) for each offered product.

• Bar code labeling (GS1-128 or HIBCC HIBC) is required on unit-of-use packaging.

• Compliance with Drug Supply Chain Security Act (DSCSA) requirements is mandatory.

• Contract Type: Firm Fixed Price, Indefinite-Delivery Requirements contract.

• Period of Performance: Base year plus four one-year option periods.

• Distribution: Products will be distributed through Government Prime Vendor (GPV) contracts.

• Payment: Contractors will receive payments from PPV programs, not directly from the Government.

• Proposals must be submitted via email in Microsoft Word or PDF format to Richard.Mahario@va.gov and Nicholas.McGregor@va.gov, including a scanned PDF of the signed SF-1449.

• Offerors must submit pricing for the base year and all four option years for all line items.

• Prices must not exceed two decimal places and must include a 0.5% Cost Recovery Fee.

• Evaluation will be based on the lowest price technically acceptable offer.

• Technical acceptability includes meeting product descriptions, NDC uniqueness, FDA approval, cGMP compliance, and manufacturing facility clearance.

• Offer due date: November 20, 2025, 2:30 PM CT.

• The acquisition is unrestricted.

• Offerors not manufacturing the items must submit a Letter of Commitment from the manufacturer.

• Offerors must maintain an active registration in the System for Award Management (SAM).

• Subcontracting plans are required for other than small business concerns if the contract value exceeds $750,000.

• Attachments A and B list the VA and DoD Pharmaceutical Prime Vendor contractors.

• Attachment C provides estimated annual requirements by agency.

• Attachment D provides a template for Small Business Subcontracting Plans.